CAAS Capital Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$693K Buy
1,400
+300
+27% +$166K 0.07% 222
2024
Q4
$574K Sell
1,100
-1,300
-54% -$677K 0.1% 153
2024
Q3
$1.18M Buy
+2,400
New +$1.12M 0.14% 138
2024
Q2
Sell
-8,700
Closed -$3.47M 369
2024
Q1
$3.47M Sell
8,700
-4,100
-32% -$1.55M 0.25% 103
2023
Q4
$4.32M Buy
12,800
+2,500
+24% +$745K 0.46% 62
2023
Q3
$3.01M Sell
10,300
-400
-4% -$125K 0.2% 134
2023
Q2
$3.66M Sell
10,700
-900
-8% -$272K 0.24% 120
2023
Q1
$2.96M Buy
11,600
+2,600
+29% +$641K 0.16% 143
2022
Q4
$2.39M Sell
9,000
-5,800
-39% -$1.41M 0.14% 173
2022
Q3
$2.77M Buy
+14,800
New +$3.18M 0.13% 226
2022
Q2
Sell
-39,000
Closed -$11.8M 961
2022
Q1
$11.8M Buy
+39,000
New +$11.4M 0.48% 61

Other funds holding ISRG

CAAS Capital Management's ISRG Position: Q4 2024 in Review

CAAS Capital Management sold out of Intuitive Surgical (ISRG) in Q4 2024, closing a stake of 300 shares — an estimated $156K sold.

CAAS Capital Management first reported a position in ISRG in Q1 2021 and held it in 7 quarters. The position peaked at $2.64M in Q3 2022. 2,129 funds tracked by Wall St. Rank hold ISRG as of Q4 2024.

  • CAAS Capital Management reported no remaining Intuitive Surgical position as of Q4 2024 after selling out during the quarter.
  • CAAS Capital Management sold 300 Intuitive Surgical shares in Q4 2024, an estimated $156K.
  • CAAS Capital Management first reported a position in Intuitive Surgical in Q1 2021 and held it in 7 quarters.
  • CAAS Capital Management's Intuitive Surgical position peaked at $2.64M in Q3 2022.
  • 2,129 funds tracked by Wall St. Rank held Intuitive Surgical as of Q4 2024.

Based on CAAS Capital Management's 13F filing for Q4 2024, filed 24 Jan 2025.